It was proposed that the levels of Prdx2 in the CSF and the ratio of Prdx2 in the cerebrospinal fluid and the blood within 3 days of onset can be used as a biomarker to detect the severity of the disease and the clinical status of subarachnoid hemorrhage patients [206]. Here, PRDX2 is linked to subarachnoid hemorrhage.